发明名称 COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE
摘要 This invention provides a method of treating a patient afflicted with a neurodegenerative disorder, e.g., Huntington's disease (HD), comprising administering to the patient laquinimod as an add-on therapy to or in combination with pridopidine. This invention also provides a package and a pharmaceutical composition comprising laquinimod and pridopidine for treating a patient afflicted with a neurodegenerative disorder, e.g., HD. This invention also provides laquinimod for use as an add-on therapy or in combination with pridopidine in treating a patient afflicted with a neurodegenerative disorder, e.g., HD. This invention further provides use of laquinimod and pridopidine in the preparation of a combination for treating a patient afflicted with a neurodegenerative disorder, e.g., HD.
申请公布号 US2014088140(A1) 申请公布日期 2014.03.27
申请号 US201314040586 申请日期 2013.09.27
申请人 HAYDEN MICHAEL;BAR-ZOHAR DAN;TEVA PHARMACEUTICAL INDUSTRIES, LTD. 发明人 HAYDEN MICHAEL;BAR-ZOHAR DAN
分类号 A61K31/4704;A61K31/451 主分类号 A61K31/4704
代理机构 代理人
主权项
地址
您可能感兴趣的专利